These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6283539)

  • 1. Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.
    Slovin SF; Frisman DM; Tsoukas CD; Royston I; Baird SM; Wormsley SB; Carson DA; Vaughan JH
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2649-53. PubMed ID: 6283539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens.
    Salahuddin SZ; Ablashi DV; Hunter EA; Gonda MA; Sturzenegger S; Markham PD; Gallo RC
    Int J Cancer; 1987 Feb; 39(2):198-202. PubMed ID: 3026971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts.
    Thorley-Lawson DA; Schooley RT; Bhan AK; Nadler LM
    Cell; 1982 Sep; 30(2):415-25. PubMed ID: 6291768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
    Yokochi T; Holly RD; Clark EA
    J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.
    Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA
    Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
    Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against Epstein-Barr virus transformed B lymphocytes from a CLL patient.
    Guha AK; Ghose T; Luner SJ; Nolido-Cruz H; Uniyal S; Rajaraman R; Fernandez LA; Lee SS; Lee CL
    Hybridoma; 1990 Apr; 9(2):119-32. PubMed ID: 2161403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of antibody production by an antigen-specific EBV-transformed B-lymphoblastoid cell line: effect of high-dose antigen and antigen-pulsed T cells.
    McCaughan GW; Brown MH; Callard RE
    Immunology; 1986 Aug; 58(4):597-602. PubMed ID: 3015782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity.
    Rowe M; Hildreth JE; Rickinson AB; Epstein MA
    Int J Cancer; 1982 Apr; 29(4):373-81. PubMed ID: 6282762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of monoclonal antibodies against lymphocyte surface antigens on interleukin 2 excretion by Epstein-Barr virus-specific human T-cell hybridomas.
    Lakow ES; Valentine MA; Vaughan JH; Tsoukas CD; Carson DA
    Cell Immunol; 1984 Apr; 85(1):67-74. PubMed ID: 6325024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epstein-Barr virus (EBV) alters the B cell glycolipid which is recognized by the human monoclonal antibody to i-blood group antigen.
    Nagatsuka Y; Yamaki M; Watarai S; Yasuda T; Higashi H; Yamagata T; Ono Y
    Virus Res; 1996 Jul; 43(1):57-68. PubMed ID: 8822634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock protein 90 expression in Epstein-Barr virus-infected B cells promotes gammadelta T-cell proliferation in vitro.
    Kotsiopriftis M; Tanner JE; Alfieri C
    J Virol; 2005 Jun; 79(11):7255-61. PubMed ID: 15890964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of several new antigens, including a T cell-associated antigen, following conversion of the EBV-negative B cell line RAMOS to EHRB-RAMOS by Epstein-Barr virus.
    Rosenthal KS; Shuman H; Strominger JL
    J Immunol; 1981 Aug; 127(2):746-54. PubMed ID: 6166685
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
    Klein G; Ehlin-Henriksson B; Schlossman SF
    J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the Epstein-Barr virus nuclear antigen as probed with monoclonal antibodies.
    Hearing JC; Lewis A; Levine AJ
    Virology; 1985 Apr; 142(1):215-20. PubMed ID: 2997981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.
    Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the phenotype and immunoglobulin secretion of human B cells following co-culture with cells of an EBV+ lymphoblastoid line or fusion with mouse plasmacytoma cells. Studies in short-term and long-term culture.
    Ling NR; Lowe JA
    Clin Exp Immunol; 1989 Feb; 75(2):311-6. PubMed ID: 2539279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes.
    Jondal M; Klein G
    J Exp Med; 1973 Dec; 138(6):1365-78. PubMed ID: 4357682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.